FI914354A - Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi - Google Patents

Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi Download PDF

Info

Publication number
FI914354A
FI914354A FI914354A FI914354A FI914354A FI 914354 A FI914354 A FI 914354A FI 914354 A FI914354 A FI 914354A FI 914354 A FI914354 A FI 914354A FI 914354 A FI914354 A FI 914354A
Authority
FI
Finland
Prior art keywords
preparing
controlled release
release formulation
core
releasing
Prior art date
Application number
FI914354A
Other languages
English (en)
Swedish (sv)
Other versions
FI93924B (fi
FI93924C (fi
FI914354A0 (fi
Inventor
Martti Lauri Antero Marvola
Taina Sirkiae
Original Assignee
Martti Lauri Antero Marvola
Taina Sirkiae
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martti Lauri Antero Marvola, Taina Sirkiae filed Critical Martti Lauri Antero Marvola
Publication of FI914354A0 publication Critical patent/FI914354A0/fi
Priority to FI914354A priority Critical patent/FI93924C/fi
Priority to PCT/FI1992/000242 priority patent/WO1993005769A1/en
Priority to CA002119158A priority patent/CA2119158A1/en
Priority to AT92919730T priority patent/ATE135204T1/de
Priority to EP92919730A priority patent/EP0605514B1/en
Priority to DE69209080T priority patent/DE69209080T2/de
Publication of FI914354A publication Critical patent/FI914354A/fi
Publication of FI93924B publication Critical patent/FI93924B/fi
Application granted granted Critical
Publication of FI93924C publication Critical patent/FI93924C/fi
Priority to US08/611,552 priority patent/US5849330A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI914354A 1991-09-17 1991-09-17 Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi FI93924C (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI914354A FI93924C (fi) 1991-09-17 1991-09-17 Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
PCT/FI1992/000242 WO1993005769A1 (en) 1991-09-17 1992-09-16 Controlled release pharmaceutical preparations
CA002119158A CA2119158A1 (en) 1991-09-17 1992-09-16 Controlled release pharmaceutical preparations
AT92919730T ATE135204T1 (de) 1991-09-17 1992-09-16 Pharmazeutische zusammemsetzungen mit verzoegerter freigabe
EP92919730A EP0605514B1 (en) 1991-09-17 1992-09-16 Controlled release pharmaceutical preparations
DE69209080T DE69209080T2 (de) 1991-09-17 1992-09-16 Pharmazeutische zusammemsetzungen mit verzoegerter freigabe
US08/611,552 US5849330A (en) 1991-09-17 1996-03-06 Controlled release pharmaceutical

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI914354 1991-09-17
FI914354A FI93924C (fi) 1991-09-17 1991-09-17 Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi

Publications (4)

Publication Number Publication Date
FI914354A0 FI914354A0 (fi) 1991-09-17
FI914354A true FI914354A (fi) 1993-03-18
FI93924B FI93924B (fi) 1995-03-15
FI93924C FI93924C (fi) 1995-06-26

Family

ID=8533138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914354A FI93924C (fi) 1991-09-17 1991-09-17 Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi

Country Status (7)

Country Link
US (1) US5849330A (fi)
EP (1) EP0605514B1 (fi)
AT (1) ATE135204T1 (fi)
CA (1) CA2119158A1 (fi)
DE (1) DE69209080T2 (fi)
FI (1) FI93924C (fi)
WO (1) WO1993005769A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
DE69735581T2 (de) * 1996-09-30 2007-01-25 Alza Corp., Palo Alto Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
EP1690531A3 (en) * 1996-09-30 2010-01-20 Alza Corporation Dosage form and method for administering drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
AU760593B2 (en) 1999-02-02 2003-05-15 Wright Medical Technology, Inc. Controlled release composite
EG23951A (en) 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US20110171296A1 (en) * 2000-10-30 2011-07-14 Biohit Oyj Method and preparation for binding acetaldehyde in saliva, the stomach and the large intestine
FI121528B (fi) * 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
US6712897B2 (en) * 2001-05-21 2004-03-30 National Gypsum Properties, Llc. Pre-blend composition, and method of making joint compound using same
WO2003037244A2 (en) * 2001-10-29 2003-05-08 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
FI122914B (fi) * 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809917A (en) * 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical tablets
NL109293C (fi) * 1955-12-22
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB2120942B (en) * 1982-05-27 1985-10-30 Glaxo Group Ltd Salbutamol compositions
US4594359B1 (en) * 1982-05-27 1994-07-26 Glaxo Group Ltd Pharmaceutical compositions
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
GB2137493A (en) * 1983-03-28 1984-10-10 Dr Kishan Narain Mathur Weight reducing composition
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
ES2071312T3 (es) * 1990-05-03 1995-06-16 Searle & Co Composicion farmaceutica.
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati

Also Published As

Publication number Publication date
ATE135204T1 (de) 1996-03-15
WO1993005769A1 (en) 1993-04-01
FI93924B (fi) 1995-03-15
DE69209080T2 (de) 1996-08-01
CA2119158A1 (en) 1993-04-01
FI93924C (fi) 1995-06-26
EP0605514B1 (en) 1996-03-13
EP0605514A1 (en) 1994-07-13
FI914354A0 (fi) 1991-09-17
US5849330A (en) 1998-12-15
DE69209080D1 (de) 1996-04-18

Similar Documents

Publication Publication Date Title
FI914354A (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
NL980012I1 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
HUT65374A (en) Process for producing of dialkylene-piperidino compounds,their enantiomers and pharmaceutical compositions comprising them
HUT61751A (en) Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
YU31000A (sh) Sferoidi, postupak za dobijanje i farmaceutske kompozicije
MY104065A (en) New pharmaceutical preparation
HUT49358A (en) Process for producing phosphorous compounds, pharmaceutical compositions comprising same as active ingredient and intermediaries
HUT59145A (en) Process for producing substituted azole derivatives and pharmaceutical compositions such compounds as active ingredient
HUT56270A (en) Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient
ATE23110T1 (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung.
HUT47131A (en) Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient
PT1124539E (pt) Formulacao farmaceutica compreendendo omeprazole
GR3019505T3 (en) Sustained-release pharmaceutical preparation and process for preparing the same
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
MX9201295A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contienen.
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HU9201189D0 (en) Amidino-phenyl-alanine derivatives as wll as method for producing said compounds and pharmaceutical preparatives containing them
HUT53897A (en) Process for producing benzopyran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
PL299376A1 (en) Method of making solid dosage units of controllable release
HUT56359A (en) Process for producing leukotriene antagonist compounds and pharmaceutical compositions comprising same as active ingredient
MX9207269A (es) Bencimidazoles substituidos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
HUT54123A (en) Process for producing new 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT61740A (en) Process for producing 2-piperidinyl-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT58068A (en) Process for producing new, pharmacologically active compounds and pharmaceutical composition comprising same as acvtive ingredient
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
BB Publication of examined application